Cannabis is one of the world’s most talked-about topics and the Hemp.im cannabis news application focuses on the latest news, social change, economic trends, and medical information in the industry.

The
app also covers the entire spectrum of companies involved in the hemp industry,
including hemp stocks listed in the U.S., Canada and other markets such as
Canopy Growth, Tilray, and Aurora Cannabis.

Emerald
Health highlights

Net sales doubled to $9.3 million from the prior quarter

Net loss of $17.5 million impacted by a $2.8 million inventory write-down and a decrease of $9.1 million in fair value adjustments of biological assets

Total SG&A expenses of $10.1 million which is lower than the Q2 expenses of $12.4 million

A second consecutive quarter of positive adjusted EBITDA at $2.4 million in Q3 2019

$5.5 million positive working capital shows an improvement from the working capital in the previous quarter ($4.2 million

Pure
Sunfarms highlights

Net sales were $24 million. The sales volume was almost 50% higher than the previous quarter

Gross margin before non-cash adjustments to the fair value of inventory and biological assets was 69%

EBITDA was $18.2 million, an EBITDA margin of 73%

Net cash and cash equivalents as of Sept. 30 were $16.1 million, up from $2.4 million as of Dec. 31, 2018.

Net loss of $2.4 million reflects a non-cash adjustment to the fair value of inventory and biological assets

The total production cost of $0.63 per gram, compared to $0.65 per gram in Q2

Emerald Health recognized a loss of $1.2 million from its 50% share of the Pure Sunfarms joint venture, compared to $14.5 million in Q2

Financing
and capital resources

Emerald’s net sales doubled to $9.3 million from the prior quarter. (Source)

During 1Q19, Emerald filed a short-form prospectus in
each of the provinces of Canada that qualifies for the issuing and secondary
sale of $150 million of common shares or other specified securities.

It also initiated an at-the-market (ATM) equity program,
under which it has raised gross proceeds of $18.8 million as of Nov. 29, 2019.

On Sept. 10, 2019, the company closed a secured
convertible debenture offering of 2,500 units at a price of $10,000 per
convertible debenture unit for gross proceeds of $25 million to a single
Canadian institutional accredited investor.

Pure
Sunfarms and Emerald’s 50% joint venture

Pure Sunfarms (PSF) reached its annualized full production run rate of 75,000 kg in its 1.1 million square foot Delta 3 facility and is now converting its nearly identical 1.1 million square foot Delta 2 facility to cannabis production.

PSF aims to complete its first harvest at Delta 2 in Q2 2020 and achieve full run-rate production in the fourth quarter of 2020, subject to completion of construction and the receipt of Health Canada licenses.

Pure Sunfarms continues to work toward additional provincial supply agreements for its high-quality dried flower cannabis product across Canada and plans to roll out other products such as pre-rolls, oils, and vapes in the coming months.

DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Hemp.im, its management, staff or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements.
These forward-looking statements generally are identified by the words
“believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar
expressions. These forward-looking statements involve known and unknown risks
as well as uncertainties, including those discussed in the following cautionary
statements and elsewhere in this article and on this site. Although the Company
may believe that its expectations are based on reasonable assumptions, the
actual results that the Company may achieve may differ materially from any
forward-looking statements, which reflect the opinions of the management of the
Company only as of the date hereof. Additionally, please make sure to read
these important
disclosures.

First
published in Le Lezard, a third-party contributor translated and
adapted the article from the original. In case of discrepancy, the original
will prevail.

Although
we made reasonable efforts to provide accurate translations, some parts may be
incorrect. Hemp.im assumes no responsibility for errors, omissions or
ambiguities in the translations provided on this website. Any person or entity
relying on translated content does so at their own risk. Hemp.im is not responsible
for losses caused by such reliance on the accuracy or reliability of translated
information. If you wish to report an error or inaccuracy in the translation,
we encourage you to contact us.

Philip Gregg is a tech biz writer, with a keen understanding of blockchain technology, Internet of Things, and cloud services. He also serves as chief consultant for an IT business in Washington and a cryptowallet startup in Tokyo. Philip holds an MBA in finance and has previously worked at a Silicon Valley company before striking out on his own. He is a dad to three German Shepherds and owns a sweet vintage Mustang he fondly calls Sadie.

Comments are closed for this post.

Download Hemp.im

Get the latest Hempnews delivered staright to your pocket with Hemp.im!

Download Hemp.im App

Get the latest Hemp news delivered straight to your pocket with Hemp.im!

Stay in touch with us

HEMP.IM uses cookies in order to improve your experience and make further customizations to how we present our content. By continuing to use our website, you accept and give your consent to our practices as described in the following: our revised Privacy Policy, Cookie Policy, and Terms of Use.I CONSENT